CY1108091T1 - Βιολογικως ενεργα παραγωγα μπλε του μεθυλενιου - Google Patents
Βιολογικως ενεργα παραγωγα μπλε του μεθυλενιουInfo
- Publication number
- CY1108091T1 CY1108091T1 CY20071100633T CY071100633T CY1108091T1 CY 1108091 T1 CY1108091 T1 CY 1108091T1 CY 20071100633 T CY20071100633 T CY 20071100633T CY 071100633 T CY071100633 T CY 071100633T CY 1108091 T1 CY1108091 T1 CY 1108091T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methylene blue
- biological energy
- energy producers
- producers
- biological
- Prior art date
Links
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 title 1
- 229960000907 methylthioninium chloride Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/003—Thiazine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/232—Solid substances, e.g. granules, powders, blocks, tablets layered or coated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μία ένωση φαινοθειαζινίου του Τύπου (I), όπου τα Α και Β είναι το καθένα ξεχωριστά (α) ή (β) στα οποία το Ζ είναι CH2, Ο, S, SO2, ΝΗ, NCH3, NC2H5, NCH2CH2OH, ή NCOCH3 και τα R1 και R2 είναι το καθένα ξεχωριστά γραμμικό ή διακλαδισμένο CnH2nY, όπου n είναι 1-6, Υ είναι Η, F, CI, Br, I, OH, OCH3, OC2H5, OC3H7, CN ή OCOCH3, και όπου ΧP- είναι ένα αντίθετο ανιόν και Ρ είναι 1, 2 ή 3 αλλά που δεν συμπεριλαμβάνει μία ένωση όπου τα Α και Β είναι και τα δύο είτε -N(CH3)2 είτε -N(CH2CH3)2. Η εφεύρεση επίσης αναφέρεται στη χρήση μίας ένωσης της εφεύρεσης ως παράγοντα PDT ή ως φωτοδιαγνωστικό παράγοντα.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0113121.8A GB0113121D0 (en) | 2001-05-30 | 2001-05-30 | Biologically active photosensitisers |
| GBGB0123945.8A GB0123945D0 (en) | 2001-05-30 | 2001-10-05 | Biologically active photosensitisers |
| EP02726300A EP1392666B1 (en) | 2001-05-30 | 2002-05-30 | Biologically active methylene blue derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1108091T1 true CY1108091T1 (el) | 2014-02-12 |
Family
ID=26246135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20071100633T CY1108091T1 (el) | 2001-05-30 | 2007-05-10 | Βιολογικως ενεργα παραγωγα μπλε του μεθυλενιου |
Country Status (21)
| Country | Link |
|---|---|
| US (6) | US7371744B2 (el) |
| EP (3) | EP2275416A1 (el) |
| JP (2) | JP4554198B2 (el) |
| KR (3) | KR100957260B1 (el) |
| CN (2) | CN100491362C (el) |
| AT (1) | ATE355282T1 (el) |
| AU (1) | AU2002256784B2 (el) |
| BR (1) | BR0209783A (el) |
| CA (1) | CA2448303C (el) |
| CY (1) | CY1108091T1 (el) |
| DE (1) | DE60218454T2 (el) |
| DK (1) | DK1392666T3 (el) |
| ES (1) | ES2280533T3 (el) |
| GB (2) | GB0113121D0 (el) |
| HK (1) | HK1063788A1 (el) |
| MX (1) | MXPA03010916A (el) |
| NO (1) | NO324321B1 (el) |
| NZ (1) | NZ529682A (el) |
| PT (1) | PT1392666E (el) |
| WO (1) | WO2002096896A1 (el) |
| ZA (1) | ZA200309215B (el) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
| US20060212025A1 (en) * | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
| GB0113121D0 (en) | 2001-05-30 | 2001-07-18 | Univ Leeds | Biologically active photosensitisers |
| US7368221B2 (en) * | 2002-06-17 | 2008-05-06 | Verification Technologies, Inc. | Changing light absorption by disruption of conjugation |
| JP2006522660A (ja) | 2003-04-10 | 2006-10-05 | ライト バイオサイエンス，エルエルシー | 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置 |
| US20050149150A1 (en) | 2003-07-31 | 2005-07-07 | Light Bioscience L.L.C. | System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| GB0322756D0 (en) * | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
| KR20060111536A (ko) * | 2003-11-28 | 2006-10-27 | 포토파미카 리미티드 | 생물학적 활성 메틸렌 블루 유도체(２)의 개발 |
| US7326258B2 (en) | 2004-06-18 | 2008-02-05 | L'oreal S.A. | Compositions comprising hydroxyalkyl direct dyes, implementation processes and uses thereof |
| BRPI0503921A (pt) * | 2004-06-18 | 2006-07-18 | Oreal | composição cosmética, processos para tintura das fibras queratìnicas, processo para clareamento das fibras queratìnicas, dispositivo com múltiplos compartimentos, uso de composto hidroxialquilado e uso de uma composição de tintura |
| US8240312B2 (en) | 2004-09-09 | 2012-08-14 | Osnat Feuerstein | Method and means for exerting a phototoxic effect of visible light on microorganisms |
| WO2006034219A2 (en) * | 2004-09-17 | 2006-03-30 | The General Hospital Corporation | Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums |
| GB0420888D0 (en) * | 2004-09-20 | 2004-10-20 | Photopharmica Ltd | Compounds and uses |
| GB0420893D0 (en) | 2004-09-20 | 2004-10-20 | Photopharmica Ltd | Photosensitisers and their uses |
| JP5186212B2 (ja) * | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物（ｍｔｃ）などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
| PT2322517T (pt) | 2004-09-23 | 2019-07-30 | Wista Lab Ltd | Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc) |
| WO2006036885A2 (en) * | 2004-09-24 | 2006-04-06 | Verification Technologies, Inc. | Changing light absorption by disruption of conjugation |
| US7101997B2 (en) * | 2004-10-07 | 2006-09-05 | Honeywell International Inc. | Method for producing phenothiazinium compounds |
| US20060222592A1 (en) * | 2005-04-05 | 2006-10-05 | Clemens Burda | Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications |
| GB0602125D0 (en) * | 2006-02-03 | 2006-03-15 | Univ Belfast | Sensitizer-incorporated biomaterials |
| WO2007127894A2 (en) * | 2006-04-28 | 2007-11-08 | Ondine International Ltd. | Photodisinfection delivery devices & methods |
| US7956183B2 (en) | 2006-07-11 | 2011-06-07 | Wista Laboratories Ltd. | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| US20080139991A1 (en) * | 2006-12-08 | 2008-06-12 | Ondine International, Ltd. | Method of wound disinfecting and tissue welding |
| CN101631780A (zh) * | 2007-04-03 | 2010-01-20 | 普罗瑟塔生物谐成公司 | 用于抗病毒治疗的吩噻嗪衍生物 |
| EP2749552B1 (en) * | 2007-04-17 | 2015-11-18 | Codman & Shurtleff, Inc. | Curcumin-resveratrol hybrids |
| US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
| US20080269205A1 (en) * | 2007-04-27 | 2008-10-30 | Ondine International, Ltd. | Methods to prevent vertical transmission of infectious diseases |
| US20090035725A1 (en) * | 2007-08-02 | 2009-02-05 | Ondine International, Ltd. | Photodisinfection of oral cavity |
| US20090093470A1 (en) * | 2007-10-08 | 2009-04-09 | Ondine International, Ltd. | Photodynamic therapy process and photosensitizer compositions therefor |
| WO2009102756A1 (en) * | 2008-02-13 | 2009-08-20 | Andreas Rose | Light delivery device that provides a radial light output pattern |
| US7985776B2 (en) | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
| WO2010014676A1 (en) | 2008-08-01 | 2010-02-04 | Ondine International Ltd. | Composition and method for treatment of mrsa |
| WO2010036617A1 (en) * | 2008-09-23 | 2010-04-01 | Ondine International Holdings Ltd. | Portable photodynamic disinfection light delivery device for catheter disinfection |
| MX2011003277A (es) * | 2008-10-14 | 2012-09-21 | Salubrious Pharmaceuticals LLC | Proceso para el tratamiento de la artritis reumatoide, temblores/enfermedad de parkinson, esclerosis multiple y cancer de tipo no viral. |
| US7723515B1 (en) * | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
| US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
| US20100256125A1 (en) * | 2009-04-06 | 2010-10-07 | Zila Pharmaceuticals, Inc. | Use of improved toluidine blue in photodynamic therapy |
| EP2544725A1 (en) * | 2010-03-08 | 2013-01-16 | Novartis AG | Active oxygen disinfection system and use thereof |
| JP5868955B2 (ja) * | 2010-04-30 | 2016-02-24 | プロセッタ アンチバイラル インコーポレイテッド | 抗ウイルス化合物 |
| US8828986B2 (en) | 2011-04-20 | 2014-09-09 | Prosetta Antiviral Inc. | Antiviral compounds |
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| WO2012125983A1 (en) | 2011-03-17 | 2012-09-20 | Prosetta Antiviral Inc. | Antiviral treatments |
| US20120301904A1 (en) | 2011-04-26 | 2012-11-29 | Prosetta Antiviral, Inc | Multiprotein assemblies |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| EP2774625B1 (en) * | 2011-09-05 | 2017-04-12 | Hiroshi Maeda | Polymer-type fluorescent molecule probe |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| US9226038B2 (en) | 2012-11-12 | 2015-12-29 | Roger B. and Ann K. McNamee Trust U/T/A/D | Systems and methods for communicating a live event to users using the internet |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| EP3473253A1 (en) | 2014-10-29 | 2019-04-24 | University Of Maryland | Methods of treating age-related symptoms in mammals and compositions therefor |
| WO2016065488A1 (en) * | 2014-10-31 | 2016-05-06 | Klox Technologies Inc. | Photoactivatable fibers and fabric media |
| KR102557319B1 (ko) * | 2015-03-30 | 2023-07-18 | 타리스 바이오메디컬 엘엘씨 | 상부 요로로의 약물의 국부적인 전달을 위한 장치 및 방법 |
| CN106901871B (zh) * | 2015-12-23 | 2021-08-24 | 爱博诺德(北京)医疗科技股份有限公司 | 具有一个或多个附加部分的人工晶状体 |
| JP7006940B2 (ja) | 2016-01-29 | 2022-01-24 | ニオバスク ティアラ インコーポレイテッド | 流出の閉塞を回避するための人工弁 |
| US10189862B2 (en) | 2016-06-14 | 2019-01-29 | The Chinese University Of Hong Kong | Phenothiazine-pyridine compounds and uses thereof |
| CN113893064A (zh) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
| WO2018126107A1 (en) * | 2016-12-29 | 2018-07-05 | Board Of Regents, The University Of Texas System | Methylene blue solution for the treatment of oral lesions |
| KR101988240B1 (ko) * | 2017-02-27 | 2019-06-12 | 주식회사 디알나노 | 피부질환에 사용되는 메틸렌 블루 복합체 및 이의 용도 |
| US20200230238A1 (en) * | 2017-08-08 | 2020-07-23 | Board Of Trustees Of Michigan State University | Tunable luminescent organic salts for enhanced imaging and photodynamic therapy |
| WO2019036810A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | TRANSCATHETER MITRAL VALVULE PROSTHESIS WITH SEQUENTIAL DEPLOYMENT |
| JP7260930B2 (ja) | 2018-11-08 | 2023-04-19 | ニオバスク ティアラ インコーポレイテッド | 経カテーテル僧帽弁人工補綴物の心室展開 |
| US11998447B2 (en) | 2019-03-08 | 2024-06-04 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
| US11510876B2 (en) | 2019-03-29 | 2022-11-29 | Mayo Foundation For Medical Education And Research | In vivo targeting of extracellular vesicles |
| CN113811265A (zh) | 2019-04-01 | 2021-12-17 | 内奥瓦斯克迪亚拉公司 | 能够以可控的方式部署的假体瓣膜 |
| US11491006B2 (en) | 2019-04-10 | 2022-11-08 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
| CN114025813B (zh) | 2019-05-20 | 2024-05-14 | 内奥瓦斯克迪亚拉公司 | 具有止血机构的引入器 |
| JP2022537559A (ja) | 2019-06-20 | 2022-08-26 | ニオバスク ティアラ インコーポレイテッド | 薄型人工補綴僧帽弁 |
| WO2023186737A1 (en) | 2022-04-01 | 2023-10-05 | Lllt Technologies Sa | Photodynamic light therapy apparatus and methods for treating oral disease |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3579339A (en) | 1967-05-23 | 1971-05-18 | Du Pont | Photopolymerizable dispersions and elements containing nonmigratory photoreducible dyes |
| US3641016A (en) * | 1968-02-16 | 1972-02-08 | Egyt Gyogyszervegyeszeti Gyar | Thionine derivatives |
| US4001587A (en) * | 1975-10-24 | 1977-01-04 | Panchenkov Georgy Mitrofanovic | Color indicator-dosimeter of ionizing radiation |
| JPS6020740B2 (ja) * | 1976-07-14 | 1985-05-23 | 株式会社リコー | カラ−像形成用感光材料 |
| EP0128414A3 (en) | 1983-06-06 | 1986-09-10 | The Hilton - Davis Chemical Company | Method of sanitizing toilets |
| US4622395A (en) | 1984-10-01 | 1986-11-11 | Minnesota Mining And Manufacturing Company | Phenoxazine and phenothiazine dyes and leuco forms thereof |
| DE3644369A1 (de) | 1986-12-24 | 1988-07-07 | Basf Ag | Verfahren zur uebertragung von kationischen farbstoffen in ihrer deprotonierten, elektrisch neutralen form |
| JPS63187154A (ja) | 1987-01-29 | 1988-08-02 | Kishida Kagaku Kk | 酸素検知剤 |
| DE3710282A1 (de) | 1987-03-28 | 1988-10-13 | Hoechst Ag | Photopolymerisierbares gemisch und daraus hergestelltes aufzeichnungsmaterial |
| US4844896A (en) * | 1987-11-02 | 1989-07-04 | Lim Technology Laboratories, Inc. | Microencapsulated insecticidal pathogens |
| JP2879080B2 (ja) | 1989-03-23 | 1999-04-05 | 株式会社リコー | 電界発光素子 |
| US5270144A (en) * | 1989-07-10 | 1993-12-14 | Tomoegawa Paper Co., Ltd. | Toner for developing static charge images |
| US5545516A (en) | 1990-05-01 | 1996-08-13 | The American National Red Cross | Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light |
| WO1991016911A1 (en) * | 1990-05-01 | 1991-11-14 | The American National Red Cross | Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light |
| US5220009A (en) * | 1990-05-03 | 1993-06-15 | Yeda Research And Development Company Limited | Phenothiazinium salts and their use for disinfecting aqueous effluents |
| US5344928A (en) * | 1991-04-26 | 1994-09-06 | Takeda Chemical Industries, Ltd. | Phenothiazine derivatives, their production and use |
| JPH05170752A (ja) * | 1991-04-26 | 1993-07-09 | Takeda Chem Ind Ltd | ３，７−ビス（ジ置換アミノ）フェノチアジン誘導体およびその製造法 |
| US5358876A (en) | 1991-07-17 | 1994-10-25 | Mitsubishi Gas Chemical Company, Inc. | Oxygen indicator |
| US5239405A (en) | 1991-09-06 | 1993-08-24 | Donnelly Corporation | Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same |
| JP4564596B2 (ja) * | 1992-04-30 | 2010-10-20 | ユーシーエル ビジネス ピーエルシー | レーザー治療 |
| JP3690825B2 (ja) * | 1993-07-26 | 2005-08-31 | エーザイ株式会社 | 三環式ヘテロ環含有スルホンアミドおよびスルホン酸エステル誘導体 |
| US5635059A (en) | 1994-10-20 | 1997-06-03 | Aqua-Ion Systems, Inc. | Method and apparatus for water treatment and purification using gas ion plasma source and disinfectant metal ion complexes |
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| JPH08305026A (ja) * | 1995-05-12 | 1996-11-22 | Fuji Photo Film Co Ltd | 画像記録方法 |
| DK0814847T3 (da) | 1996-01-16 | 2004-03-15 | Zila Inc | Fremgangsmåder og sammensætninger til in vivo bestemmelse af orale cancere og præcancer-tilstande |
| DE19640758C2 (de) | 1996-10-02 | 1999-11-04 | Rafael Lachky | Mittel zur Behandlung von Diskusfischen |
| WO1998031219A1 (en) * | 1997-01-21 | 1998-07-23 | The American National Red Cross | Intracellular and extracellular decontamination of whole blood and blood components by amphiphilic phenothiazin-5-ium dyes plus light |
| US20040055965A1 (en) | 1997-06-13 | 2004-03-25 | Hubig Stephan M. | Recreational water treatment employing singlet oxygen |
| US6251127B1 (en) | 1997-08-25 | 2001-06-26 | Advanced Photodynamic Technologies, Inc. | Dye treatment solution and photodynamic therapy and method of using same |
| US5811471A (en) * | 1997-09-15 | 1998-09-22 | Shanbrom Technologies Llc | Disinfectant plastic sponge material |
| DE19750303A1 (de) | 1997-11-13 | 1999-05-20 | Henkel Kgaa | Verwendung von alkylierten Phenothiazinen zum Färben von keratinhaltigen Fasern |
| US7229447B1 (en) | 1998-08-25 | 2007-06-12 | Advanced Photodynamics Technologies, Inc. | Photodynamic therapy utilizing a solution of photosensitizing compound and surfactant |
| US8267982B2 (en) | 1998-08-25 | 2012-09-18 | Advanced Photodynamic Technologies, Inc. | Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| US6562295B1 (en) | 1999-06-30 | 2003-05-13 | Ceramoptec Industries, Inc. | Bacteria resistant medical devices |
| JP2001124699A (ja) | 1999-10-28 | 2001-05-11 | Miura Co Ltd | 溶存酸素濃度測定用指示薬 |
| WO2001070699A1 (fr) | 2000-03-22 | 2001-09-27 | Bf Research Institute, Inc. | Analogues d'azur a utilises comme sondes dans l'imagerie diagnostique des maladies dues a l'accumulation d'amyloide, et compositions renfermant ces analogues destinees a l'imagerie diagnostique |
| WO2001085213A2 (en) * | 2000-05-08 | 2001-11-15 | The University Of British Columbia | Supports for photosensitizer formulations |
| US6551346B2 (en) | 2000-05-17 | 2003-04-22 | Kent Crossley | Method and apparatus to prevent infections |
| FR2810318B1 (fr) | 2000-06-15 | 2005-09-23 | Laurent Galey | Derives de diamano-phenothiazine |
| WO2002089750A2 (en) | 2001-01-19 | 2002-11-14 | Advanced Photodynamic Technologies, Inc. | Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin |
| GB2373787A (en) | 2001-03-08 | 2002-10-02 | Univ Central Lancashire | Phenothiazinium derivatives and their use to reduce pathogenic contaminants |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| GB0113121D0 (en) * | 2001-05-30 | 2001-07-18 | Univ Leeds | Biologically active photosensitisers |
| EP1414471B1 (en) | 2001-07-17 | 2012-06-13 | Research Development Foundation | Therapeutic agents comprising pro-apoptotic proteins |
| US6551171B1 (en) * | 2002-01-24 | 2003-04-22 | Brian Hass | Brassiere with detachable uniform pressure assembly |
| US6952392B2 (en) | 2002-06-17 | 2005-10-04 | Verification Technologies, Inc. | Laser reactive dyes for DVD copy protection system |
| US7176308B2 (en) | 2002-06-17 | 2007-02-13 | Verification Technologies, Inc. | Processes for preparing novel methylene blue derivative |
| GB0420888D0 (en) | 2004-09-20 | 2004-10-20 | Photopharmica Ltd | Compounds and uses |
| US7220879B2 (en) | 2004-10-01 | 2007-05-22 | Rohm And Haas Company | Method for inhibiting polymerization of (meth)acrylic acid and its esters using an inhibitor and a process for making a compound useful as such an inhibitor |
-
2001
- 2001-05-30 GB GBGB0113121.8A patent/GB0113121D0/en not_active Ceased
- 2001-10-05 GB GBGB0123945.8A patent/GB0123945D0/en not_active Ceased
-
2002
- 2002-05-30 KR KR1020097000876A patent/KR100957260B1/ko not_active IP Right Cessation
- 2002-05-30 BR BR0209783-4A patent/BR0209783A/pt not_active Application Discontinuation
- 2002-05-30 ES ES02726300T patent/ES2280533T3/es not_active Expired - Lifetime
- 2002-05-30 EP EP10184827A patent/EP2275416A1/en not_active Withdrawn
- 2002-05-30 WO PCT/GB2002/002278 patent/WO2002096896A1/en active Application Filing
- 2002-05-30 MX MXPA03010916A patent/MXPA03010916A/es active IP Right Grant
- 2002-05-30 JP JP2003500075A patent/JP4554198B2/ja not_active Expired - Fee Related
- 2002-05-30 NZ NZ529682A patent/NZ529682A/xx not_active IP Right Cessation
- 2002-05-30 DE DE60218454T patent/DE60218454T2/de not_active Expired - Lifetime
- 2002-05-30 EP EP02726300A patent/EP1392666B1/en not_active Expired - Lifetime
- 2002-05-30 CN CNB028126963A patent/CN100491362C/zh not_active Expired - Fee Related
- 2002-05-30 KR KR1020097011462A patent/KR20090061684A/ko not_active Application Discontinuation
- 2002-05-30 PT PT02726300T patent/PT1392666E/pt unknown
- 2002-05-30 DK DK02726300T patent/DK1392666T3/da active
- 2002-05-30 AU AU2002256784A patent/AU2002256784B2/en not_active Ceased
- 2002-05-30 EP EP07003393A patent/EP1790642A1/en not_active Ceased
- 2002-05-30 KR KR10-2003-7015653A patent/KR20040015723A/ko not_active Application Discontinuation
- 2002-05-30 CN CN200910140884XA patent/CN101928262A/zh active Pending
- 2002-05-30 AT AT02726300T patent/ATE355282T1/de active
- 2002-05-30 CA CA2448303A patent/CA2448303C/en not_active Expired - Fee Related
-
2003
- 2003-11-26 ZA ZA2003/09215A patent/ZA200309215B/en unknown
- 2003-11-26 US US10/723,420 patent/US7371744B2/en not_active Expired - Fee Related
- 2003-11-28 NO NO20035327A patent/NO324321B1/no not_active IP Right Cessation
-
2004
- 2004-09-01 HK HK04106589A patent/HK1063788A1/xx not_active IP Right Cessation
-
2007
- 2007-05-10 CY CY20071100633T patent/CY1108091T1/el unknown
-
2008
- 2008-04-04 US US12/078,805 patent/US7915254B2/en not_active Expired - Fee Related
- 2008-05-12 US US12/149,996 patent/US8188074B2/en not_active Expired - Fee Related
- 2008-06-18 US US12/141,747 patent/US7855197B2/en not_active Expired - Fee Related
- 2008-07-10 US US12/171,121 patent/US7732439B2/en not_active Expired - Fee Related
-
2009
- 2009-07-06 JP JP2009160062A patent/JP2009280588A/ja active Pending
-
2012
- 2012-04-23 US US13/453,855 patent/US20120302557A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108091T1 (el) | Βιολογικως ενεργα παραγωγα μπλε του μεθυλενιου | |
| IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
| DK1289972T3 (da) | Serinproteaseinhibitorer | |
| MXPA04004347A (es) | Nuevos fotoindicadores difuncionales. | |
| DK1385514T5 (da) | Spiroinden- og spiroindanforbindelser | |
| DE69915004D1 (de) | 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate | |
| SE0004245D0 (sv) | Novel compounds and their use | |
| PT1975164E (pt) | Compostos de octa-hidrobenzimidazolona utilizados como analgésicos | |
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| DE60015390D1 (de) | Antidiabetische thiazolidindione und ihre herstellung | |
| PT882726E (pt) | Carbazol-carboxamidas como agonistas 5-ht1f | |
| TR200302288T2 (tr) | Terapi için yeni bileşikler ve metotlar. | |
| BR0115996A (pt) | Sulfamidotienopirimidinas | |
| DE60101639D1 (de) | Ein (1'R,2'S,5'R)-3-l-Menthoxypropan-1-ol, das eine kühlende Empfindung erzeugt | |
| DK1204659T3 (da) | Serotonerge benzofuraner | |
| DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| EA200200807A1 (ru) | Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece | |
| BR0112849A (pt) | Processo para a preparação de um composto quiral, e, composto quiral | |
| TR199902097A2 (xx) | Mikrobial transformasyon. | |
| IT1317000B1 (it) | Uso di composti di origine naturale ad attivita' antiangiogenica. | |
| TH42384A (th) | อนุพันธ์ d-โปรไลน์ |